|

University of Central Florida Music Study

RECRUITINGN/ASponsored by University of Central Florida
Actively Recruiting
PhaseN/A
SponsorUniversity of Central Florida
Started2025-08-28
Est. completion2026-03
Eligibility
Age50 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07306065

Summary

The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive method to assess physiological changes.

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* 50 years old or older.

  * 20 adults with no mild-cognitive impairment
  * 20 adults with mild-cognitive impairment
  * 20 adults with Alzheimer's disease/ dementia.
* participant or the participant's legally authorized representative must be able to read or speak English and agree to comply with study procedures.
* pregnant women may chose to participate

Exclusion Criteria:

* 49 years and younger
* prisoners
* unable to understand English and provide consent

Conditions4

Alzheimer's DiseaseAlzheimers DiseaseDementiaDementia Alzheimer Type

Locations1 site

University of Central Florida
Orlando, Florida, 32827
Amoy Fraser, PhD, CCRP, PMP4072668742Amoy.Fraser@ucf.edu

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.